METROPOLITAN LIFE INSURANCE CO/NY - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$10,241
-39.2%
6,0600.0%0.00%0.0%
Q2 2023$16,847
+101.7%
6,060
+32.0%
0.00%
Q1 2023$8,354
-66.7%
4,590
-7.3%
0.00%
-100.0%
Q4 2022$25,112
+2.0%
4,9530.0%0.00%0.0%
Q3 2022$24,616
+258.8%
4,953
+168.6%
0.00%
Q2 2022$6,860
-73.7%
1,844
-60.3%
0.00%
-100.0%
Q1 2022$26,081
-77.3%
4,649
-75.4%
0.00%
-50.0%
Q4 2021$114,754
-38.6%
18,874
-1.7%
0.00%
-33.3%
Q3 2021$187,037
-31.8%
19,2030.0%0.00%
-25.0%
Q2 2021$274,219
+22.0%
19,203
+102.8%
0.00%
+33.3%
Q1 2021$224,8429,4710.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders